STS718 treatment showed a trend in reducing the levels of proteinuria compared with vehicle-treated group, though statistically significance did not reach ( Figure S3 B-C ).
← all excerpts
<i>In vivo</i> Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis.
1
—
—